What You Should Know Today

In 1996, Doug Olson was diagnosed with chronic lymphocytic leukemia (CLL) and underwent various treatments including chemotherapy. When the cancer stopped responding to treatment, he was recommended CAR T-cell therapy, a type of immunotherapy that reengineers immune cells to target cancer cells more effectively. CAR T-cell therapy has shown promising results for blood cancers, with a high rate of remission in some cases. Side effects include cytokine release syndrome and potential effects on the brain. While there are still challenges to overcome, CAR T-cell therapy has been a lifesaving treatment for many patients and shows potential for targeting solid tumors in the future.

Source link

error: Content is protected !!